Inventor · disambiguated record
Toshihiko Hibino
Also filed as: HIBINO TOSHIHIKO
10 granted patents·15 pending applications·62 citations·filing 1973–2020
85Inventor score
Top patents by PatentIndex Score
25 records- 0192US3932400AThiazole derivativesSUMITOMO CHEMICAL CO·Filed 1973·Granted Jan 13, 1976·45 cites·10 claims
- 0272US4130566AProcess for producing 5-carboxy-2-acetylthiopheneSUMITOMO CHEMICAL CO·Filed 1977·Granted Dec 19, 1978·6 cites·9 claims
- 0359US2011165607A1Method for evaluating status of skin barrier function of natural moisturizing factor using bleomycin hydrolase activity as indicatorSHISEIDO CO LTD·Filed 2009·Application pending·0 cites
- 0457US9063157B2Method for evaluating skin condition using squamous cell carcinoma antigen as markerKATAGIRI CHIKA·Filed 2006·Granted Jun 23, 2015·2 cites·8 claims
- 0554US2019079080A1Antibody specific to profilaggrin c-terminal domain, and use thereofSHISEIDO CO LTD·Filed 2018·Application pending·0 cites
- 0652US2007172444A1Hair tonics and method of screening the sameSHISEIDO CO LTD·Filed 2007·Application pending·0 cites
- 0751US9068228B2Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicatorSHISEIDO CO LTD·Filed 2014·Granted Jun 30, 2015·0 cites·1 claims
- 0850US2020215139A1Bleomycin hydrolase production promotorSHISEIDO CO LTD·Filed 2020·Application pending·0 cites
- 0950US2006153794A1Hair tonics and method of screening the sameSHISEIDO CO LTD·Filed 2005·Application pending·0 cites
- 1049US7829547B2Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigenSHISEIDO CO LTD·Filed 2005·Granted Nov 9, 2010·0 cites·1 claims
- 1144US2014287431A1Antibody specific to profilaggrin c-terminal domain, and use thereofSHISEIDO CO LTD·Filed 2012·Application pending·0 cites
- 1242US3951998ABenzothiazole derivativesSUMITOMO CHEMICAL CO·Filed 1974·Granted Apr 20, 1976·2 cites·6 claims
- 1341US6120765AUrokinase plasminogen activator fragmentsGEN HOSPITAL CORP·Filed 1993·Granted Sep 19, 2000·6 cites·13 claims
- 1441US2004022758A1Hair tonics and method of screening the sameFiled 2001·Application pending·0 cites
- 1538US2003157536A1Human II type 5alpha-reductase promoter gene and uses thereofFiled 2001·Application pending·0 cites
- 1637US2012244140A1Screening method for substance capable of promoting recovery of skin barrier function technical fieldHIBINO TOSHIHIKO·Filed 2010·Application pending·0 cites
- 1737US2005215509A1Method for inhibiting jnk-1 kinase activity by SCCASHISEIDO CO LTD·Filed 2005·Application pending·0 cites
- 1835US8906629B2Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicatorHIBINO TOSHIHIKO·Filed 2010·Granted Dec 9, 2014·0 cites·1 claims
- 1935US2009208985A1Method Of Evaluating Degree Of Skin Sensitivity Using Squamous Cell Carcinoma Antigen As An Indicator ThereofKATAGIRI CHIKA·Filed 2007·Application pending·0 cites
- 2032US2011305783A1Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigenHIBINO TOSHIHIKO·Filed 2010·Application pending·0 cites
- 2132US2014010901A1Bleomycin hydrolase production promotorHIBINO TOSHIHIKO·Filed 2012·Application pending·0 cites
- 2231US6818214B2Two novel genes from psoriatic epidermis: psoriastatin type I and psoriastatin type IIGEN HOSPITAL CORP·Filed 1996·Granted Nov 16, 2004·1 cites·9 claims
- 2330US2007160545A1Method for reducing ultraviolet light induced apoptosisKATAGIRI CHIKA·Filed 2005·Application pending·0 cites
- 2429US4153610AProcess for producing 5-carboxy-2-acetylthiopheneSUMITOMO CHEMICAL CO·Filed 1977·Granted May 8, 1979·0 cites·7 claims
- 2526US2013129845A1Screening method for chronic inflammation inhibitors or cancer metastasis inhibitors using inhibition of binding between emmprin and s100a9 as indexHIBINO TOSHIHIKO·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →